Clinical Trial Update: BBV152/BBV154 Heterologus Prime-Boost Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BBV152/BBV154 heterologous prime-boost regimen in Corona Virus Infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• BBV152/BBV154

Snippet

Sponsor: Bharat Biotech International Limited | Conditions: Corona Virus Infection | Phase 2 | Status: COMPLETED